Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C K Stover

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|August 29, 2018
Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity <i>In Vitro</i> and Staphylococcus aureus Fitness in Infection ModelsC Tkaczyk, E Semenova, Y Y Shi, et al.
The Journal of Experimental Medicine|December 1, 1994
Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein AS Langermann, S R Palaszynski, J E Burlein, et al.
Science (New York, N.Y.)|June 14, 1996
Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosisD R Sherman, K Mdluli, M J Hickey, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in miceM J Hickey, T M Arain, R M Shawar, et al.
Annals of the New York Academy of Sciences|January 1, 1990
A structural and immunological comparison of rickettsial HSP60 antigens with those of other speciesG A Dasch, W M Ching, P Y Kim, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia ModelL Hua, T S Cohen, Y Shi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 1995
Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteriaD R Sherman, P J Sabo, M J Hickey, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulareR M Shawar, D J Humble, J M Van Dalfsen, et al.
Infection and Immunity|April 1, 1994
Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulenceL Pascopella, F M Collins, J M Martin, et al.
Advances in Experimental Medicine and Biology|January 11, 1992
Use of recombinant BCG as a vaccine delivery vehicleC K Stover, V F de la Cruz, G P Bansal, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|August 29, 2018
Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity <i>In Vitro</i> and Staphylococcus aureus Fitness in Infection ModelsC Tkaczyk, E Semenova, Y Y Shi, et al.
The Journal of Experimental Medicine|December 1, 1994
Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein AS Langermann, S R Palaszynski, J E Burlein, et al.
Science (New York, N.Y.)|June 14, 1996
Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosisD R Sherman, K Mdluli, M J Hickey, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1996
Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in miceM J Hickey, T M Arain, R M Shawar, et al.
Annals of the New York Academy of Sciences|January 1, 1990
A structural and immunological comparison of rickettsial HSP60 antigens with those of other speciesG A Dasch, W M Ching, P Y Kim, et al.
Antimicrobial Agents and Chemotherapy|May 20, 2015
MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia ModelL Hua, T S Cohen, Y Shi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 1995
Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteriaD R Sherman, P J Sabo, M J Hickey, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulareR M Shawar, D J Humble, J M Van Dalfsen, et al.
Infection and Immunity|April 1, 1994
Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulenceL Pascopella, F M Collins, J M Martin, et al.
Advances in Experimental Medicine and Biology|January 11, 1992
Use of recombinant BCG as a vaccine delivery vehicleC K Stover, V F de la Cruz, G P Bansal, et al.
Pageof 6